Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Mission Bay Capital
3942
Mission Bay Capital
Suggest edits
Follow us
Also headquartered in San Francisco
Ahelpfulghost
Twitter
Uber
Instagram
TikTok
Lyft
Airbnb
Coinbase
Fitbit
LinkedIn
Overview
News
Investments
21
Portfolio
Portfolio Tracker
Add info
Add round
22 Jul
2021
Noble Foods
$75,000,000
Venture capital (Series B)
Andreessen Horowitz
,
Hillhouse Capital Group
,
Mission Bay Capital
,
+9
BREAKING: Plant-based cheesemaker Nobell Foods nets $75m from a16z, AgFunder & Breakthrough Energy
AFN
27 Jul
2018
Alector
$133,000,000
Venture capital (Series E)
Polaris Partners
,
Foresite Capital
,
New Leaf Venture Partners
,
+14
Biotech Company Alector Raises $133M in Series E Financing
FinSMEs
+1
17 Apr
2018
GraphWear
$4,200,000
Venture capital (Series A)
Mission Bay Capital
,
Bio Innovation Capital
After moving to San Francisco, GraphWear Technologies raises $4.2M Series A
Technical.ly
13 Dec
2017
Pionyr Immunotherapeutics
$62,000,000
Venture capital (Series B)
Osage University Partners
,
Sofinnova Ventures
,
OrbiMed
,
+4
05 Dec
2017
Asilomar Bio
$12,250,000
Venture capital (Series B)
Cultivian Sandbox Ventures
,
Syngenta Ventures
,
Mission Bay Capital
,
+2
28 Jun
2017
Vivace Therapeutics, Inc.
$25,000,000
Venture capital (Series B)
Canaan Partners
,
Sequoia Capital
,
WuXi Healthcare Ventures
,
+2
Cancer-Focused Vivace Emerges with $40M in Financing Genetic Engineering & Biotechnology News - Biotech from Bench to Business
GEN
+1
06 Jan
2017
SiteOne Therapeutics
$15,000,000
Venture capital (Series B)
2M Companies
,
NEXT Frontier Capital
,
Mission Bay Capital
,
+4
Amgen Partners with SiteOne to Develop Pain Treatments Genetic Engineering & Biotechnology News - Biotech from Bench to Business
GEN
+1
04 Jan
2017
Pionyr Immunotherapeutics
$8,000,000
Venture capital (Series A)
Osage University Partners
,
SV Life Sciences
,
OrbiMed
,
+1
Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics
prnewswire
+1
21 Dec
2016
Circle Pharma
$4,500,000
Venture capital (Series A)
Mission Bay Capital
,
Pfizer
,
ShangPharma
Circle Pharma Raises over $4.5M in Series A Funding
FinSMEs
08 Sep
2016
Chrono Therapeutics
$47,600,000
Venture capital (Series B)
Canaan Partners
,
Endeavour Vision
,
GE Ventures
,
+10
Chrono Therapeutics Closes $47.6M Series B Financing
FinSMEs
+1
02 Jun
2016
Cell Design Labs
$34,400,000
Venture capital
Kleiner Perkins Caufield & Byers
,
Osage University Partners
,
Mission Bay Capital
,
+1
Cell Design raises $34.4M, partners with Kite
biocentury
16 May
2016
Caribou Biosciences
$30,000,000
Venture capital (Series B)
Heritage Group
,
Novartis
,
F-Prime Capital Partners
,
+5
Caribou Biosciences Completes $30M Series B Funding
FinSMEs
06 May
2016
ViewPoint Therapeutics
$4,000,000
Venture capital (Series A)
Asset Management Ventures (AMV)
,
Mission Bay Capital
,
Biotechnology Value Fund
,
+3
ViewPoint Therapeutics Closes $4M Series A Financing
FinSMEs
07 Jan
2016
Alector
$29,500,000
Venture capital (Series D)
Polaris Partners
,
OrbiMed
,
Topspin Partners
,
+6
Alector Raises $29.5M in Series D Financing
FinSMEs
15 Jul
2015
SiteOne Therapeutics
$1,280,000
Venture capital
NEXT Frontier Capital
,
Mission Bay Capital
,
Sears Capital Management
,
+1
SiteOne Therapeutics Secures Investment
Venture Funding News
10 Sep
2014
Zephyrus Biosciences
$1,500,000
Seed fund
StartX
,
Mission Bay Capital
,
The Angels' Forum
,
+4
22 Apr
2014
Principia Biopharma
$50,000,000
Venture capital (Series B)
Morgenthaler Ventures
,
New Leaf Venture Partners
,
SR One
,
+3
20 May
2013
Effector Therapeutics
$45,000,000
Venture capital
Osage University Partners
,
SR One
,
Novartis Venture Fund
,
+4
29 Oct
2012
Principia Biopharma
$12,500,000
Venture capital (Series A)
Morgenthaler Ventures
,
New Leaf Venture Partners
,
SR One
,
+2
08 Jul
2010
Calithera Biosciences
$40,000,000
Venture capital (Series A)
Advanced Technology Ventures
,
Morgenthaler Ventures
,
U.S. Venture Partners (USVP)
,
+2